SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-001618
Filing Date
2020-05-15
Accepted
2020-05-15 16:14:22
Documents
39
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cns_10q-033120.htm 10-Q 236824
2 AMENDED AND RESTATED ARTICLES OF INCORPORATION cns_10q-ex0301.htm EX-3.1 30171
3 CERTIFICATION BY CHIEF EXECUTIVE OFFICER cns_10q-ex3101.htm EX-31.1 7624
4 CERTIFICATION BY CHIEF FINANCIAL OFFICER cns_10q-ex3102.htm EX-31.2 7635
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER cns_10q-ex3201.htm EX-32.1 3768
6 CERTIFICATION BY CHIEF FINANCIAL OFFICER cns_10q-ex3202.htm EX-32.2 3697
  Complete submission text file 0001683168-20-001618.txt   1611700

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cnsp-20200331.xml EX-101.INS 210067
8 XBRL SCHEMA FILE cnsp-20200331.xsd EX-101.SCH 18516
9 XBRL CALCULATION FILE cnsp-20200331_cal.xml EX-101.CAL 26002
10 XBRL DEFINITION FILE cnsp-20200331_def.xml EX-101.DEF 83328
11 XBRL LABEL FILE cnsp-20200331_lab.xml EX-101.LAB 165637
12 XBRL PRESENTATION FILE cnsp-20200331_pre.xml EX-101.PRE 135669
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39126 | Film No.: 20885355
SIC: 2834 Pharmaceutical Preparations